The sensitivity of endodontic enterococcus Spp. Strains to geranium essential oil

Molecules

Volumn 20, Issue 12, 2015, Pages 22881-22889

  Łysakowska, Monika E ^a   Sienkiewicz, Monika ^a   Banaszek, Katarzyna ^a   Sokołowski, Jerzy ^a   McPhee, Derek J ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Endodontic treatment; Enterococci; Geranium essential oil

Indexed keywords

ANTIINFECTIVE AGENT; ESSENTIAL OIL; VEGETABLE OIL;

BIOFILM; CELL LINE; CHEMISTRY; DRUG EFFECTS; ENDODERM; ENTEROCOCCUS; GERANIUM; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PROCEDURES; SENSITIVITY AND SPECIFICITY;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BIOFILMS; CELL LINE; ENDODERM; ENTEROCOCCUS; GERANIUM; HUMANS; MICROBIAL SENSITIVITY TESTS; OILS, VOLATILE; PLANT OILS; SENSITIVITY AND SPECIFICITY;

EID: 84954338862     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules201219888     Document Type: Article

References (36)

1. Sedgley, C.M.; Lennan, S.L.; Clewell, D.B. Prevalence, phenotype and genotype of oral enterococci. Oral Microbiol. Immunol. 2004, 19, 95-101.
2. Sedgley, C.M.; Molander, A.; Flannagan, S.E.; Nagel, A.C.; Appelbe, O.K.; Clewell, D.B.; Dahlén, G. Virulence, phenotype and genotype characteristics of endodontic Enterococcus spp. Oral Microbiol. Immunol. 2005, 20, 10-19.
3. Hollenbeck, B.L.; Rice, L.B. Intrinsic and acquired resistance mechanisms in Enterococcus. Virulence 2012, 3, 421-433.
4. De Niederhäusern, S.; Bondi, M.; Messi, P.; Iseppi, R.; Sabia, C.; Manicardi, G.; Anacarso, I. Vancomycin-resistance transferability from VanA enterococci to Staphylococcus aureus. Curr. Microbiol. 2011, 62, 1363-1367.
5. Reichling, J.; Schnitzler, P.; Suschke, U. Essential oils of aromatic plants with antibacterial, antifungal, antiviral and cytotoxic properties-An oview. Forsch. Komplementmed. 2009, 16, 79-90.
6. Edris, A.E. Pharmaceutical and therapeutic potentials of essential oils and their individual volatile constituents: A review. Phytother. Res. 2007, 21, 308-323.
7. Rao, P.K.; Bobbarala, V.; Aryamithra, D.; Devi, P.S.; Rao, T.R. In vitro antibacterial activities of plant essential oils against oral bacteria. Ind. J. Multidiscip. Res. 2008, 4, 507-516.
8. Prabuseenivasan, S.; Jayakumar, M.; Ignacimuthu, S. In vitro antibacterial activity of some plant essential oils. BMC Complement. Altern. Med. 2006, 6.
9. Maruyama, N.; Sekimoto, Y.; Ishibashi, H.; Shigeharu, I.; Oshima, H.; Yamaguchi, H.; Abe, S. Suppression of neutrophil accumulation in mice by cutaneous application of geranium essential oil. J. Inflamm. 2005, 2, 1-11.
10. Rosato, A.; Vitali, C.; de Laurentiis, N.; Armenise, D.; Milillo, M.A. Antibacterial effect of some essential oils administered alone or in combination with Norfloxacin. Phytomedicine 2007, 14, 727-732.
11. Sienkiewicz, M.; Poznańska-Kurowska, K.; Kaszuba, A.; Kowalczyk, E. The antibacterial activity of geranium oil against Gram-negative bacteria isolated from difficult-to-heal wounds. Burns 2013, 40, 1046-1051.
12. Polish Pharmacopeia, 9th ed.; Polish Pharmaceutical Society: Warsaw, Poland, 2011.
13. European Pharmacopoeia, 8th ed.; Council of Europe: Strasbourg, France, 2013.
14. Malik, T.; Singh, P. Antimicrobial effects of essential oils against uropathogens with varying sensitivity to antibiotics. Asian J. Biol. Sci. 2010, 3, 92-98.
15. Sienkiewicz, M.; Głowacka, A.; Kowalczyk, E.; Wiktorowska-Owczarek, A.; Jóźwiak-Bębenista, M.; Łysakowska, M. The biological activities of cinnamon, geranium and lavender essential oils. Molecules 2014, 19, 20929-20940.
16. Lin, L.M.; Skribner, J.E.; Gaengler, P. Factors associated with endodontic treatment failures. J. Endod. 1992, 18, 625-627.
17. Castilho, A.L.; Saraceni, C.H.; Díaz, I.E.; Paciencia, M.L.; Suffredini, I.B. New trends in dentistry: Plant extracts against Enterococcus faecalis. The efficacy compared to chlorhexidine. Braz. Oral Res. 2013, 27, 109-115.
18. Zore, G.B.; Thakre, A.D.; Rathod, V.; Karuppayil, S.M. Evaluation of anti-Candida potential of geranium oil constituents against clinical isolates of Candida albicans differentially sensitive to fluconazole: Inhibition of growth, dimorphism and sensitization. Mycoses 2011, 54.
19. Benbelaid, F.; Khadir, A.; Abdoine, M.A.; Bendahou, M.; Muselli, A.; Costa, J. Antimicrobial activity of some essential oils against oral multidrug-resistant Enterococcus faecalis in both planktonic and biofilm state. Asian Pac. J. Trop. Biomed. 2014, 4, 463-472.
20. Kotan, R.; Kordali, S.; Cakir, A. Screening of antibacterial activities of twenty-one oxygenated monoterpenes. Z. Naturforsch. C 2007, 62, 507-513.
21. Inouye, S.; Takizawa, T.; Yamaguchi, H. Antibacterial activity of essential oils and their major constituents against respiratory tract pathogens by gaseous contact. J. Antimicrob. Chemother. 2001, 47, 565-573.
22. Faleiro, M.L. The mode of antibacterial action of essential oils. In Science Against Microbial Pathogens: Communicating Current Research and Technological Advances; Formatex Research Center: Badajoz, Spain, 2011; pp. 1143-1156.
23. Szabó, M.A.; Varga, G.Z.; Hohmann, J.; Schelz, Z.; Szegedi, E.; Amaral, L.; Molnár, J. Inhibition of quorum-sensing signals by essential oils. Phytother. Res. 2010, 24, 782-786.
24. Sanchez, C.J., Jr.; Mende, K.; Beckius, M.L.; Akers, K.S.; Romano, D.R.; Wenke, J.C.; Murray, C.K. Biofilm formation by clinical isolates and the implications in chronic infections. BMC Infect. Dis. 2013, 13.
25. Davies, A.; Roberts, W. The cell wall of a chlorhexidine-resistant Pseudomonas. Biochem. J. 1969, 112, 15.
26. Hassan, K.A.; Jackson, S.M.; Penesyan, A.; Patching, S.G.; Tetu, S.G.; Eijkelkamp, B.A.; Brown, M.H.; Henderson, P.J.; Paulsen, I.T. Transcriptomic and biochemical analyses identify a family of chlorhexidine efflux proteins. Proc. Natl. Acad. Sci. USA 2013, 110, 20254-20259.
27. Kulik, E.M.; Waltimo, T.; Weiger, R.; Schweizer, I.; Lenkeit, K.; Filipuzzi-Jenny, E.; Walter, C. Development of resistance of mutans streptococci and Porphyromonas gingivalis to chlorhexidine digluconate and amine fluoride/stannous fluoride-containing mouthrinses, in vitro. Clin. Oral Investig. 2015, 19, 1547-1553.
28. Łysakowska, M.E.; Ciebiada-Adamiec, A.; Sienkiewicz, M.; Sokołowski, J.; Banaszek, K. The cultivable microbiota of primary and secondary infected root canals, their susceptibility to antibiotics and association with the signs and symptoms of infection. Int. Endod. J. 2015.
29. Syed, S.A.; Loesche, W.J. Survival of human dental plaque flora in various transport media. Appl. Microbiol. 1972, 24, 638-644.
30. Kariyama, R.; Mitsuhata, R.; Chow, J.W.; Clewell, D.B.; Kumon, H. Simple and reliable multiplex PCR assay for surveillance isolates of vancomycin-resistant enterococci. J. Clin. Microbiol. 2000, 38, 3092-3095.
31. EUCAST. Available online: http://www.eucast.org/clinical-breakpoints/ Clinical breakpoints-bacteria v 2.0 (accessed on 25 July 2012).
32. Clinical and Laboratory Standard Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: Nineteenth Informational Supplement; CLSI document M100-S19; Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2009; pp. 19087-11898.
33. Adams, R.P. Identification of Essential Oil Components by Gas Chromatography/Mass Spectroscopy, 4th ed.; Allured Publishing Corporation: Carol Stream, IL, USA, 2007.
34. Joulain, D.; König, W.A. The Atlas of Spectral Data of Sesquiterpene Hydrocarbons; E.B.-Verlag: Hamburg, Germany, 1998.
35. Andrews, J.M. Determination of minimum inhibitory concentrations. J. Antimicrob. Chemother. 2001, 48 (Suppl. S1), 5-16.
36. Baca, P.; Junco, P.; Arias-Moliz, M.T.; González-Rodríguez, M.P.; Ferrer-Luque, C.M. Residual and antimicrobial activity of final irrigation protocols on Enterococcus faecalis biofilm in dentin. J. Endod. 2011, 37, 363-366.